Aug 9, 2023 8:00 am EDT COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Jun 26, 2023 7:00 am EDT CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
May 24, 2023 7:00 am EDT CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update
May 2, 2023 9:00 am EDT COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Apr 4, 2023 8:26 am EDT Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs
Mar 29, 2023 7:00 am EDT Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update
Mar 14, 2023 7:00 am EDT COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Jan 4, 2023 7:00 am EST CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives
Jan 3, 2023 7:00 am EST CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form
